Mother's Pharmaceutical Co., Ltd. announced that it expects to receive KRW 7 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Daishin Securities Co.,Ltd
August 15, 2023
Share
Mother's Pharmaceutical Co., Ltd. announced that it will issue episodes 1 Bearer unsecured private placement convertible bonds for gross proceeds of KRW 7,000,000,000 on August 16, 2023. The transaction include the participation from Korea Investment & Securities Co., Ltd. for KRW 1,000,000,000, NH Investment & Securities Co., Ltd. for KRW 1,000,000,000, Daishin Securities Co.,Ltd for KRW 1,000,000,000 and HARANG-YC New Technology Investment Fund No. 2. for KRW 4,000,000,000.
The bonds will carry 5% Interest Rate and surface rate is 2% will mature on August 18, 2026, The bonds are fully convertible into 700,000 shares representing 5.37% stake at a fixed conversion price of KRW 10,000 each starting from August 18, 2014 to July 18, 2026. The transaction has been approved by the board of directors of the company. The payment date is on August 18, 2023 and the subscription date is August 17, 2023.
DAISHIN SECURITIES CO.,LTD is a Korea-based company specialized in the financial investment business. The Company is engaged in the securities dealing, brokerage and underwriting businesses, covering corporate bonds, government bonds, options, foreign exchanges, initial public offerings (IPOs), exchange traded funds, cash management accounts (CMAs), equity linked securities (ELSs), fund wrap accounts, investment strategy consulting and bond analysis services, among others. It also provides smart banking services. In addition, through its subsidiaries, it engages in the saving bank, asset management, economic research and other businesses.
Mother's Pharmaceutical Co., Ltd. announced that it expects to receive KRW 7 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Daishin Securities Co.,Ltd
DAISHIN SECURITIES CO.,LTD 
